Select Medical (NYSE:SEM) Shares Pass Above Two Hundred Day Moving Average – Should You Sell?

Select Medical Holdings Corporation (NYSE:SEM) crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $15.70 and traded as high as $16.56. Select Medical shares last traded at $16.5350, with a volume of 465,583 shares.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on the company. Royal Bank Of Canada reissued a “sector perform” rating and set a $16.50 target price (down from $19.00) on shares of Select Medical in a report on Tuesday, March 3rd. Wall Street Zen downgraded shares of Select Medical from a “buy” rating to a “hold” rating in a research note on Monday, March 9th. Mizuho reissued a “neutral” rating and set a $16.50 target price (down from $17.00) on shares of Select Medical in a research note on Tuesday, May 12th. Zacks Research upgraded shares of Select Medical from a “strong sell” rating to a “hold” rating in a report on Monday, May 4th. Finally, Benchmark cut shares of Select Medical from a “buy” rating to a “hold” rating in a report on Wednesday, March 4th. One analyst has rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $15.50.

Select Medical Trading Up 0.3%

The business’s 50-day moving average is $16.44 and its two-hundred day moving average is $15.70. The firm has a market cap of $2.05 billion, a P/E ratio of 15.60, a P/E/G ratio of 0.95 and a beta of 1.01. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.15 and a quick ratio of 1.15.

Select Medical (NYSE:SEM) last posted its quarterly earnings data on Thursday, April 30th. The health services provider reported $0.36 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.43 by ($0.07). Select Medical had a net margin of 2.42% and a return on equity of 6.62%. The business had revenue of $1.42 billion during the quarter, compared to the consensus estimate of $1.41 billion. During the same period in the prior year, the firm earned $0.44 EPS. The business’s revenue for the quarter was up 5.0% on a year-over-year basis. Select Medical has set its FY 2026 guidance at 1.220-1.320 EPS. As a group, analysts predict that Select Medical Holdings Corporation will post 1.26 earnings per share for the current fiscal year.

Select Medical Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, May 28th. Shareholders of record on Thursday, May 14th were issued a dividend of $0.0625 per share. The ex-dividend date was Thursday, May 14th. This represents a $0.25 annualized dividend and a yield of 1.5%. Select Medical’s dividend payout ratio is presently 23.58%.

Select Medical announced that its Board of Directors has approved a stock buyback plan on Thursday, February 19th that permits the company to repurchase $1.00 billion in shares. This repurchase authorization permits the health services provider to buy up to 49.5% of its stock through open market purchases. Stock repurchase plans are usually an indication that the company’s board of directors believes its stock is undervalued.

Hedge Funds Weigh In On Select Medical

A number of institutional investors and hedge funds have recently added to or reduced their stakes in SEM. Quarry LP purchased a new stake in Select Medical in the fourth quarter valued at approximately $26,000. Quantbot Technologies LP purchased a new position in Select Medical in the 3rd quarter worth about $27,000. Caitong International Asset Management Co. Ltd purchased a new stake in shares of Select Medical during the 4th quarter valued at about $28,000. Hantz Financial Services Inc. grew its stake in shares of Select Medical by 214.7% during the 4th quarter. Hantz Financial Services Inc. now owns 2,549 shares of the health services provider’s stock valued at $38,000 after acquiring an additional 1,739 shares during the period. Finally, Smartleaf Asset Management LLC grew its stake in shares of Select Medical by 37.8% during the 4th quarter. Smartleaf Asset Management LLC now owns 2,870 shares of the health services provider’s stock valued at $43,000 after acquiring an additional 788 shares during the period. Institutional investors own 89.48% of the company’s stock.

Select Medical Company Profile

Select Medical is a leading provider of specialized healthcare services in the United States, operating through two primary business segments: Hospital Division and Outpatient Rehabilitation Division. The Hospital Division offers long-term acute care (LTAC) hospitals and inpatient rehabilitation facilities (IRFs) that serve patients recovering from complex illnesses, trauma or surgery. The Outpatient Rehabilitation Division delivers physical, occupational and speech therapy services through a network of clinic locations and home-based care programs.

Headquartered in Mechanicsburg, Pennsylvania, Select Medical was founded in 1996 and has grown through strategic partnerships, joint ventures and acquisitions.